Seeking Alpha

ajbrzoz

ajbrzoz
Send Message
View ajbrzoz's Comments BY TICKER:
  • Why The FDA Got It Wrong And Why It Will Approve Vascepa For ANCHOR SNDA Submission [View article]
    You have said repeatedly that Amarin is dead, yet, you keep coming back to comment. If you really believed Amarin was dead and that Vascepa only had a 0.0001% chance of gaining ANCHOR approval, you wouldn't be here. I think you are worried that Vascepa will get ANCHOR because you know that AdCom was a circus.
    Nov 19 08:10 PM | 4 Likes Like |Link to Comment
  • Why The FDA Got It Wrong And Why It Will Approve Vascepa For ANCHOR SNDA Submission [View article]
    PSalerno, are you kidding? The new guidelines will double the use of statins.
    Nov 19 04:47 PM | 2 Likes Like |Link to Comment
  • Why The FDA Got It Wrong And Why It Will Approve Vascepa For ANCHOR SNDA Submission [View article]
    Hatvani, speaking up is better than remaining silent, especially when it's obvious that the FDA has done AMRN wrong.
    Nov 19 08:28 AM | 17 Likes Like |Link to Comment
  • New Study: EPA Reduces Cardiovascular Events - Enough For Amarin Approval? [View article]
    Great article!! I found it on Pubmed about a month ago and posted it on Stocktwits and Twitter. Great to see it make it to Seeking Alpha.
    Oct 21 06:03 PM | 1 Like Like |Link to Comment
  • Make It Or Break It Day Could Be At Hand For Amarin [View article]
    While the Vascepa ANCHOR AdCom is very important for AMRN, PDUFA is the golden ticket.
    Oct 11 08:15 AM | 6 Likes Like |Link to Comment
  • Drop The Anchor And Fish For Profits [View article]
    Why would BP wait until REDUCE-IT results are announced, when AMRN has ANCHOR in hand and the door is open to 40M+ patients in the US. Compare and contrast the trial designs, populations, diets, and EPA doses in REDUCE-IT and JELIS, and the question should be: "What opportunities will unfold with positive REDUCE-IT results?"

    PS- and don't forget the Vascepa/Statin combo product.
    Oct 2 12:57 PM | 3 Likes Like |Link to Comment
  • Amarin's Counterpunch: What Q2 Earnings Could Mean For The Future [View article]
    With more unaccounted for Rx's in Q'2, we could finish from $10.5-$10.8M, although I won't complain with $10.4M.
    Jul 18 11:49 AM | 3 Likes Like |Link to Comment
  • Amarin's Counterpunch: What Q2 Earnings Could Mean For The Future [View article]
    Thanks, Will!
    Jul 18 10:17 AM | Likes Like |Link to Comment
  • Amarin's 'All-In' On Vascepa Makes It A Massive Risk [View article]
    I am all in. No risk, no reward.
    Mar 27 12:59 AM | 1 Like Like |Link to Comment
  • A Top Biotech Stock To Own In 2013 [View article]
    Great article, Steve! Thank you.
    Mar 6 05:31 PM | 2 Likes Like |Link to Comment
  • Amarin: A Physician's Perspective On Vascepa [View article]
    Thanks for the article, DoctoRx!
    Feb 26 05:59 AM | Likes Like |Link to Comment
  • Amarin's Vascepa: 5 Myths Debunked [View article]
    Exactly! And why couldn't GSK ever garner a sNDA for Lovaza in the 200-500 mg/dLTrig's patient population who were on statins? Could DHA have been the culprit?

    Funny how Vascepa's ANCHOR sNDA approval is virtually a slam dunk. Remember, Alex, there's no DHA in Vascepa. Hmmmm.....

    and then there's the JELIS study............
    Feb 25 05:52 PM | 1 Like Like |Link to Comment
  • The Price May Be Increasing For An Amarin Buyout [View article]
    Despite the fact that Vascepa will be a blockbuster, whether Amarin GIA or is BO, the current pps is proof that Wall Street is hammering the stock to buy in at lower levels to make as much ROI as possible when the BO occurs. People who panicked and sold will regret it. GLTA!
    Dec 19 08:42 AM | 2 Likes Like |Link to Comment
  • Forget Amarin: Buy Celsion For A Bigger Score [View article]
    I'll stick with AMRN.
    Dec 10 01:46 PM | 4 Likes Like |Link to Comment
  • The Price May Be Increasing For An Amarin Buyout [View article]
    I hope Feuerstein reads this article and learns something about AMRN. Thanks, Steve!
    Dec 7 08:36 AM | 4 Likes Like |Link to Comment
More on AMRN by ajbrzoz
COMMENTS STATS
45 Comments
85 Likes